With a high-ranking executive at the helm, Apple is apparently continuing to enable blood sugar measurements on the Apple Watch in the future. The US financial news agency Bloomberg reports that Tim Millet is said to have taken over the management of the Exploratory Design Group. The top personnel show that Apple continues to attach great value to the project. The company itself generally does not comment on future products and therefore not on personnel.
Millet is known to the public as Vice President of Platform Architecture and is part of the chip team at Apple that caused an international sensation with the development of Apple Silicon. With 19 years of service at the company, Millet is, in a sense, already a veteran. In his role, he oversaw the conversion from Intel processors to its own M-series chips.
Research has been underway since 2011
The blood sugar project is said to have been launched at Apple in 2011. With a view to diabetes patients, non-invasive technology in the watch would be an addition to the Apple Watch, with which Apple could set itself apart from the smartwatch competition. Similar to blood pressure measurements, reliable blood sugar measurements are also considered a difficult undertaking. Apple is said to have already developed a prototype that is the size of an iPhone, but would have to be significantly reduced in size to accommodate the watch. Blood sugar measurements with the Apple Watch could warn watch wearers of an impending illness.
The Exploratory Design Group was led until the end of 2022 by Bill Athas, who passed away. According to media reports, in Apple’s secret department, the company is researching various future projects before, if successful, they are sent to the classic development departments to be brought to market maturity. Apple recently introduced the Apple Watch Series 9 and the Apple Watch Ultra 2. Both watches contain health sensors for heartbeat, blood oxygen and ECG.
To the home page
#Blood #sugar #measurement #Apple #Watch #Apparently #boss